Patient group
Erwachsene Patienten mit transfusionsabhängiger Anämie, die mit einer ꞵ-Thalassämie verbunden ist
completed2020-08-01D series
Luspatercept
β-Thalassämie
Open official case page ↗
- Brand
- Reblozyl
- Manufacturer
- Celgene GmbH
G-BA action
final resolution
2021-01-21
Arzneimittel-Richtlinie/Anlage XII: Luspatercept (β-Thalassämie)
Evidence-checked summary
The G-BA found a hint of non-quantifiable added benefit for Erwachsene Patienten mit transfusionsabhängiger Anämie, die mit einer ꞵ-Thalassämie verbunden ist. The G-BA issued a final resolution on 2021-01-21. The official page states that it took effect as follows: aufgehoben. The page lists Arzneimittel-Richtlinie as the normative target.
This is the latest validated public action attached to this case. It is separate from the IQWiG assessment result.
Final benefit result
G-BA result by patient group
Official case record
What happened, in source order
No inferred stages
Consultation record
Oral hearing and Wortprotokoll
2020-12-07
128 parsed turns
Oral hearing: Luspatercept (β-Thalassämie)
Official Wortprotokoll · 20 pages
IQWiG comparison
Assessment record versus G-BA action
IQWiG assessment findings and the later G-BA action are separate records. Open both to compare them.
No IQWiG assessment reference is present on the validated official case page. This is an explicit absence, not a broken graph link.
G-BA decisions
Distinct actions and documents
2021-01-21
final resolution
Arzneimittel-Richtlinie/Anlage XII: Luspatercept (β-Thalassämie)
The G-BA found a hint of non-quantifiable added benefit for Erwachsene Patienten mit transfusionsabhängiger Anämie, die mit einer ꞵ-Thalassämie verbunden ist. The G-BA issued a final resolution on 2021-01-21. The official page states that it took effect as follows: aufgehoben. The page lists Arzneimittel-Richtlinie as the normative target.
3 official documents · 4 cited claims
Official sources
Case document package
official case pageOfficial G-BA case pageOpen ↗gba assessment amendmentAmendment zur Nutzenbewertung des G-BAOpen ↗iqwig cost assessmentBewertung der Therapiekosten und Patientenzahlen IQWiGOpen ↗gba assessmentNutzenbewertung G-BAOpen ↗hearing transcriptWortprotokollOpen ↗decision textBeschlusstextOpen ↗decision rationaleTragende Gründe zum BeschlussOpen ↗summary documentationZusammenfassende DokumentationOpen ↗